Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Suntory Holdings Ltd | 35 |
| 2 | Barry Callebaut AG | 10 |
| 3 | Chinese Academy of Sciences | 9 |
| 4 | Kikkoman Corp | 9 |
| 5 | Nutricos Technologies SNC | 8 |
| 6 | Anheuser Busch InBev SA | 6 |
| 7 | Henkel AG and Co KGaA | 4 |
| 8 | JNC Corp | 4 |
| 9 | Salzgitter AG | 4 |
| 10 | Givaudan SA | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 144 |
| 2 | A61P | Therapeutic activity (drug indications) | 119 |
| 3 | A23L | Foods and beverages (general) | 87 |
| 4 | A61Q | Cosmetics, personal care | 63 |
| 5 | A23V | Foods, foodstuffs - indexing scheme | 61 |
| 6 | C07D | Heterocyclic compounds | 32 |
| 7 | C12C | 30 | |
| 8 | A23F | Coffee, tea; their substitutes | 23 |
| 9 | G01N | Investigating / analysing materials | 23 |
| 10 | A23C | 21 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| The extracting method of Proanthocyanidins from Grape Seeds high polymer cracking and Proanthocyanidin B3 | 2019 | 1 | |
| Composition for improving flexibility of blood vessels, composition for improving vascular endothelial function, composition for inhibiting platelet aggregation, composition for improving blood flow, and transoral composition being characterized by containing (A) catechin and (B) proanthocyanidin B3 | 2023 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Nuno Mateus | Universidade do Porto | 7 |
| 2 | Víctor de Freitas | Universidade do Porto | 6 |
| 3 | Mirei Mizuno | SHOWA Medical University | 3 |
| 4 | Rosa Pérez-Gregório | Universidade do Porto | 3 |
| 5 | Kiyoshi Fukuhara | Showa Pharmaceutical University | 3 |
| 6 | Takashi Yoshida | Okayama University | 2 |
| 7 | Seong Jun Seo | Chung-Ang University | 2 |
| 8 | Tsutomu Hatano | Okayama University | 2 |
| 9 | Seong Soo Joo | Gangneung–Wonju National University | 2 |
| 10 | Natércia F. Brás | Universidade do Porto | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Interaction between lysozyme and procyanidin: Multilevel structural nature and effect of carbohydrates | 2012 | 102 | Proteins in Food Systems |
| Determination of proanthocyanidins and catechins in beer and barley by high-performance liquid chromatography with dual-electrode electrochemical detection | 1994 | 95 | Fermentation and Sensory Analysis |
| Structural Features of Copigmentation of Oenin with Different Polyphenol Copigments | 2013 | 83 | Phytochemicals and Antioxidant Activities |
| Mechanisms of Tannin-Induced Trypsin Inhibition: A Molecular Approach | 2011 | 67 | Phytochemicals and Antioxidant Activities |
| Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor | 2010 | 64 | Prostate Cancer Treatment and Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Procyanidin B3?
Which organizations hold the most patents involving Procyanidin B3?
What are the main research areas covered by patents for Procyanidin B3?
What research topics have been explored in published papers about Procyanidin B3?
Which researchers are most active in publishing studies on Procyanidin B3?